AAD 2026Abstract 75519
Germline Pathogenic Variants Confer Increased Susceptibility to Immune-Related Adverse Events in Patients With Melanoma Treated with Immune Checkpoint Inhibitors
Shen A, Arbesman M, Newell D, Chen J, Arbesman J, Funchain P, Kennedy L
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Skin cancer & tumorsGenetic skin disease
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.943 · Not in PubMed: details from Crossref